{
    "medicine_id": "b8d2a990f5fcdf02008af087a1fe745492698bfc",
    "platform_id": "DB11431",
    "metadata": {
        "name": "Moxidectin 2 mg 1mg Tablet",
        "composition": "2 mg 1mg Moxidectin",
        "clinical_particulars": {
            "therapeutic_indications": "Moxidectin is indicated for the treatment of river blindness also called onchocerciasis in patients aged 12 years and older River blindness is caused by a parasitic worm _Onchocerca volvulus_ and it is manifested as severe itching disfiguring skin conditions and visual impairment caused by the worm s larvae L2971 The transmission of _Onchocerca volvulus_ is performed person to person by black flies that breed in fast flowing rivers in sub Saharan Africa Yemen and South and Central America The larvae released by the adult parasite invade skin and eyes where they can produce the severe disease manifestations L2971",
            "contraindications": {
                "disease": "Moxidectin is reported to be safe as it is reported to be a poor substrate of P glycoprotein A33385 The reported LD50in mice are in the range of 70 131 micromol kg A33397 Carcinogenicity studies have not been performed Moxidectin was shown to present no effects in genotoxicity mutagenicity and fertility FDA label The reports of overdose there are related to the presence of transient and self limiting neurological signs including the presence of convulsions F139",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Moxidectin has been reported to be highly effective against _Onchocerca volvulus_ when compared to ivermectin A33398 When moxidectin was administered in infected individuals the microfilarial load in the skin was lower even when compared to the current therapy ivermectin The levels of microfilarial got reduced to an undetectable level while being safe to be used in mass drug administration L2986",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}